Reata Pharmaceuticals, Inc. (RETA) News Headlines

▮ More

Date

Headline

2/28/2019 6:51:30 AM Reata Pharma Q4 Net Loss $25.6 Mln Or $0.86/Shr Vs Loss $16.7 Mln Or $0.64/shr Last Year

1/7/2019 8:39:07 PM AXSM Awes Investors, LOXO Snapped Up For $8 Bln, SAGE Excited, TLC On Watch

1/7/2019 7:16:17 AM Reata Pharmaceuticals Appoints Geoffrey Block VP, Nephrology

11/7/2018 7:20:09 AM Reata Pharma Q3 Net Loss $30.8 Mln Or $1.07/shr Vs. Net Loss $12.3 Mln Or $0.50/shr Last Year

9/2/2018 11:13:15 AM 10 Pharma Stocks To Watch This Month

8/7/2018 3:21:30 AM CRY Has Reason To Smile, AKCA Braces For Busy Year, GEMP Down After-hours

7/24/2018 9:16:16 PM Reata Pharma Announces Pricing Of Offering Of 3 Mln Shares Of Class A Common Stock At $72.00/shr

7/23/2018 4:40:15 PM Reata Pharmaceuticals Announces Proposed Public Offering Of Class A Common Stock

7/23/2018 10:04:49 AM Reata Pharmaceuticals Inc. (RETA) Has Jumped To A New High On Study Results

7/23/2018 6:52:29 AM Reata Announces Results From Two Phase 2 Studies Of Bardoxolone Methyl In Chronic Kidney Disease Patients

6/14/2018 4:31:09 PM Reata Pharmaceuticals Secures $125 Mln Term Loan Facility

6/4/2018 7:35:43 AM Reata Pharma Says Kyowa Hakko Kirin Initiated Ayame, A Phase 3 Trial Of Bardoxolone Methyl For Diabetic Kidney Disease

5/25/2018 5:51:14 AM Will PHOENIX Make RETA Fly?

5/25/2018 3:34:05 AM Reata Reports Presentation Of Positive Interim Data From ADPKD And IgA Nephropathy Cohorts Of Phase 2 PHOENIX Trial

5/19/2018 1:26:12 AM An Ear To The Pharma: 11 Stocks To Watch (DOVA, SESN, URGN…)

5/9/2018 1:46:02 AM AKCA Faces FDA Panel Tomorrow, ALDR To Report Data In June, TCMD Riding High

3/22/2018 7:33:20 AM Reata Announces Positive Top-Line Data For Treatment Of PH-ILD With Bardoxolone Methyl From Phase 2 Lariat Trial

3/2/2018 7:34:23 AM Reata Pharma Q4 Net Loss $16.7 Mln Or $0.64/Shr Vs Loss Of $4.1 Mln Or $0.19/Shr Last Year

Older Articles